BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

365 related articles for article (PubMed ID: 18937968)

  • 1. RUNX3 protein is overexpressed in human epithelial ovarian cancer.
    Nevadunsky NS; Barbieri JS; Kwong J; Merritt MA; Welch WR; Berkowitz RS; Mok SC
    Gynecol Oncol; 2009 Feb; 112(2):325-30. PubMed ID: 18937968
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Frequent inactivation of RUNX3 in endometrial carcinoma.
    Yoshizaki T; Enomoto T; Fujita M; Ueda Y; Miyatake T; Fujiwara K; Miyake T; Kimura T; Yoshino K; Kimura T
    Gynecol Oncol; 2008 Sep; 110(3):439-44. PubMed ID: 18572225
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of RUNX3 gene, methylation status and clinicopathological significance in breast cancer and breast cancer cell lines.
    Jiang Y; Tong D; Lou G; Zhang Y; Geng J
    Pathobiology; 2008; 75(4):244-51. PubMed ID: 18580070
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Profiling follicle stimulating hormone-induced gene expression changes in normal and malignant human ovarian surface epithelial cells.
    Ho SM; Lau KM; Mok SC; Syed V
    Oncogene; 2003 Jul; 22(27):4243-56. PubMed ID: 12833147
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of RUNX3 in skin cancers.
    Lee JH; Pyon JK; Kim DW; Lee SH; Nam HS; Kang SG; Kim CH; Lee YJ; Chun JS; Cho MK
    Clin Exp Dermatol; 2011 Oct; 36(7):769-74. PubMed ID: 21623876
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Possible involvement of RUNX3 silencing in the peritoneal metastases of gastric cancers.
    Sakakura C; Hasegawa K; Miyagawa K; Nakashima S; Yoshikawa T; Kin S; Nakase Y; Yazumi S; Yamagishi H; Okanoue T; Chiba T; Hagiwara A
    Clin Cancer Res; 2005 Sep; 11(18):6479-88. PubMed ID: 16166423
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selection of potential markers for epithelial ovarian cancer with gene expression arrays and recursive descent partition analysis.
    Lu KH; Patterson AP; Wang L; Marquez RT; Atkinson EN; Baggerly KA; Ramoth LR; Rosen DG; Liu J; Hellstrom I; Smith D; Hartmann L; Fishman D; Berchuck A; Schmandt R; Whitaker R; Gershenson DM; Mills GB; Bast RC
    Clin Cancer Res; 2004 May; 10(10):3291-300. PubMed ID: 15161682
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Frequent silencing of RUNX3 in esophageal squamous cell carcinomas is associated with radioresistance and poor prognosis.
    Sakakura C; Miyagawa K; Fukuda KI; Nakashima S; Yoshikawa T; Kin S; Nakase Y; Ida H; Yazumi S; Yamagishi H; Okanoue T; Chiba T; Ito K; Hagiwara A; Ito Y
    Oncogene; 2007 Aug; 26(40):5927-38. PubMed ID: 17384682
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The immunomodulatory protein B7-H4 is overexpressed in breast and ovarian cancers and promotes epithelial cell transformation.
    Salceda S; Tang T; Kmet M; Munteanu A; Ghosh M; Macina R; Liu W; Pilkington G; Papkoff J
    Exp Cell Res; 2005 May; 306(1):128-41. PubMed ID: 15878339
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The lysophosphatidic acid (LPA) receptors their expression and significance in epithelial ovarian neoplasms.
    Wang P; Wu X; Chen W; Liu J; Wang X
    Gynecol Oncol; 2007 Mar; 104(3):714-20. PubMed ID: 17204312
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of the jun family of genes in human ovarian cancer and normal ovarian surface epithelium.
    Neyns B; Katesuwanasing ; Vermeij J; Bourgain C; Vandamme B; Amfo K; Lissens W; DeSutter P; Hooghe-Peters E; DeGrève J
    Oncogene; 1996 Mar; 12(6):1247-57. PubMed ID: 8649827
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Inhibition of invasive and chemotactic abilities of SKOV3 cells by human epithelial growth receptor-2 small interfering RNA].
    Zhang SL; Lu YM; Meng LR; Zhao YY
    Zhonghua Fu Chan Ke Za Zhi; 2007 Jan; 42(1):48-53. PubMed ID: 17331422
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential gene expression profiles between tumor biopsies and short-term primary cultures of ovarian serous carcinomas: identification of novel molecular biomarkers for early diagnosis and therapy.
    Bignotti E; Tassi RA; Calza S; Ravaggi A; Romani C; Rossi E; Falchetti M; Odicino FE; Pecorelli S; Santin AD
    Gynecol Oncol; 2006 Nov; 103(2):405-16. PubMed ID: 16725184
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of SPARC expression in reactive stroma associated with human epithelial ovarian cancer.
    Brown TJ; Shaw PA; Karp X; Huynh MH; Begley H; Ringuette MJ
    Gynecol Oncol; 1999 Oct; 75(1):25-33. PubMed ID: 10502421
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression status of RUNX1/AML1 in normal gastric epithelium and its mutational analysis in microdissected gastric cancer cells.
    Usui T; Aoyagi K; Saeki N; Nakanishi Y; Kanai Y; Ohki M; Ogawa K; Yoshida T; Sasaki H
    Int J Oncol; 2006 Oct; 29(4):779-84. PubMed ID: 16964375
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Claudin-3 and claudin-4 expression in ovarian epithelial cells enhances invasion and is associated with increased matrix metalloproteinase-2 activity.
    Agarwal R; D'Souza T; Morin PJ
    Cancer Res; 2005 Aug; 65(16):7378-85. PubMed ID: 16103090
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effects of small interfering RNA specific for Her-2 gene on biological behavior of ovarian carcinoma cell].
    Zhou Y; Ling B; Feng DQ; Cheng ZX; Shen GD; Gao T; Shi YY; Wang MM; Zhao WD; Zhu HP
    Zhonghua Fu Chan Ke Za Zhi; 2006 Dec; 41(12):830-3. PubMed ID: 17327114
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Loss of estrogen receptor beta isoform expression and its correlation with aberrant DNA methylation of the 5'-untranslated region in human epithelial ovarian carcinoma.
    Suzuki F; Akahira J; Miura I; Suzuki T; Ito K; Hayashi S; Sasano H; Yaegashi N
    Cancer Sci; 2008 Dec; 99(12):2365-72. PubMed ID: 19032364
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patterns of gene expression in different histotypes of epithelial ovarian cancer correlate with those in normal fallopian tube, endometrium, and colon.
    Marquez RT; Baggerly KA; Patterson AP; Liu J; Broaddus R; Frumovitz M; Atkinson EN; Smith DI; Hartmann L; Fishman D; Berchuck A; Whitaker R; Gershenson DM; Mills GB; Bast RC; Lu KH
    Clin Cancer Res; 2005 Sep; 11(17):6116-26. PubMed ID: 16144910
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibin resistance is associated with aggressive tumorigenicity of ovarian cancer cells.
    Steller MD; Shaw TJ; Vanderhyden BC; Ethier JF
    Mol Cancer Res; 2005 Jan; 3(1):50-61. PubMed ID: 15671249
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.